Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2019

01-10-2019 | Magnetic Resonance Imaging

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer

Authors: Louise M. Henderson, PhD, Laura Ichikawa, MS, Diana S. M. Buist, PhD, Janie M. Lee, MD, Mary Bush, MN, Dianne Johnson, BA, Tracy Onega, PhD, Larissa Nekhlyudov, MD, Karla Kerlikowske, MD, Diana L. Miglioretti, PhD, Brian L. Sprague, PhD, Karen J. Wernli, PhD

Published in: Journal of General Internal Medicine | Issue 10/2019

Login to get access

Abstract

Background

National patterns of breast imaging in women with a personal history of breast cancer (PHBC) are unknown making evaluation of annual surveillance recommendations a challenge.

Objective

To describe variation in use of mammography and breast magnetic resonance imaging (MRI) examinations beginning 6 months after diagnosis among women with PHBC in US community practice. We report on the breast imaging indication, imaging intervals, and time since breast cancer diagnosis by examination type.

Design

Longitudinal study using cross-sectional data.

Setting

Breast Cancer Surveillance Consortium breast imaging facilities.

Participants

19,955 women diagnosed between 2005 and 2012 with AJCC stage 0-III incident breast cancer who had 69,386 mammograms and 3,553 breast MRI examinations from January 2005 to September 2013; median follow-up of 37.6 months (interquartile range, 22.1–60.7).

Main Measures

Breast imaging indication, imaging intervals, and time since breast cancer diagnosis by examination type.

Key Results

Among women with a PHBC who received breast imaging, 89.4% underwent mammography alone, 0.8% MRI alone, and 10.3% had both mammography and MRI. About half of mammograms and MRIs were indicated for surveillance vs. diagnostic, with an increase in the proportion of surveillance exams as time from diagnosis increased (mammograms, 45.7% at 1 year to 72.2% after 5 years; MRIs, 54.8% at 1 year to 78.6% after 5 years). In the first post-diagnosis period, 32.8% of women had > 2 breast imaging examinations and of these, 65.8% were less than 6 months apart. During the first 5-year post-diagnosis, the frequency of examinations per year decreased and the interval between examinations shifted towards annual examinations.

Conclusion

In women with a PHBC who received post-diagnosis imaging, a third underwent multiple breast imaging examinations per year during the first 2-year post-diagnosis despite recommendations for annual exams. As time since diagnosis increases, imaging indication shifts from diagnostic to surveillance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miller KD, Siegel RL, Lin CC, et al. Cancer Treatment and Survivorship Statistics, 2016. CA Cancer J Clin 2016;66:271–289.CrossRef Miller KD, Siegel RL, Lin CC, et al. Cancer Treatment and Survivorship Statistics, 2016. CA Cancer J Clin 2016;66:271–289.CrossRef
2.
go back to reference Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34(6):611–35.CrossRef Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34(6):611–35.CrossRef
3.
go back to reference Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE, American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.CrossRef Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE, American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.CrossRef
4.
go back to reference National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology - Breast Cancer. Fort Washington, PA: National Comprehensive Cancer Network (NCCN); 2016 [cited 2016 January 6]; Clinical Practice Guidelines in Oncology - Breast Cancer, Version 1.2016. Available from: http://nccn.org. Accessed 05/07/2019. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology - Breast Cancer. Fort Washington, PA: National Comprehensive Cancer Network (NCCN); 2016 [cited 2016 January 6]; Clinical Practice Guidelines in Oncology - Breast Cancer, Version 1.2016. Available from: http://​nccn.​org. Accessed 05/07/2019.
5.
go back to reference Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18–27.CrossRef Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18–27.CrossRef
6.
go back to reference Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DS, Geller BM, Muss HB, Irwig L. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305:790–9.CrossRef Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DS, Geller BM, Muss HB, Irwig L. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305:790–9.CrossRef
7.
go back to reference Buist DS, Abraham LA, Barlow WE, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124(3):863–873.CrossRef Buist DS, Abraham LA, Barlow WE, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124(3):863–873.CrossRef
8.
go back to reference Arasu VA, Joe BN, Lvoff NM et al. Benefit of Semiannual Ipsilateral Mammographic Surveillance Following Breast Conservation Therapy. Radiology. 2012;264(2):371–377.CrossRef Arasu VA, Joe BN, Lvoff NM et al. Benefit of Semiannual Ipsilateral Mammographic Surveillance Following Breast Conservation Therapy. Radiology. 2012;264(2):371–377.CrossRef
9.
go back to reference Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors Related to Underuse of Surveillance Mammography Among Breast Cancer Survivors. J Clin Oncol. 2006;24(1):85–94.CrossRef Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors Related to Underuse of Surveillance Mammography Among Breast Cancer Survivors. J Clin Oncol. 2006;24(1):85–94.CrossRef
10.
go back to reference Enewold L, McGlynn KA, Zahm SH, et al. Surveillance mammography among female DOD beneficiairies: as study by race and ethnicity. Cancer. 2013; 119(19): 3531–3538.CrossRef Enewold L, McGlynn KA, Zahm SH, et al. Surveillance mammography among female DOD beneficiairies: as study by race and ethnicity. Cancer. 2013; 119(19): 3531–3538.CrossRef
11.
go back to reference Onega T, Weiss J, diFlorio R, MacKenzie T, Goodrich M, Poplack S. Evaluating Surveillance Breast Imaging and Biopsy in Older Breast Cancer Survivors. Int J Breast Cancer. 2012; 2012:347646.CrossRef Onega T, Weiss J, diFlorio R, MacKenzie T, Goodrich M, Poplack S. Evaluating Surveillance Breast Imaging and Biopsy in Older Breast Cancer Survivors. Int J Breast Cancer. 2012; 2012:347646.CrossRef
12.
go back to reference Wirtz HS, Boudreau DM, Gralow JR et al. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat. 2014;143(3):541–50.CrossRef Wirtz HS, Boudreau DM, Gralow JR et al. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat. 2014;143(3):541–50.CrossRef
13.
go back to reference Ruddy KJ, Sangaralingham L, Freedman RA, et al. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018;16(5):526–534.CrossRef Ruddy KJ, Sangaralingham L, Freedman RA, et al. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. J Natl Compr Canc Netw. 2018;16(5):526–534.CrossRef
14.
go back to reference Nekhlyudov L, Habel LA, Achacoso NS, et al. Adherence to Long-Term Surveillance Mammography Among Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Surgery. J Clin Oncol. 2009;27(19):3211–3216.CrossRef Nekhlyudov L, Habel LA, Achacoso NS, et al. Adherence to Long-Term Surveillance Mammography Among Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Surgery. J Clin Oncol. 2009;27(19):3211–3216.CrossRef
15.
go back to reference Nekhlyudov L, Habel LA, Achacoso N, et al. Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS. J Natl Cancer Inst. 2012;104:614–621.CrossRef Nekhlyudov L, Habel LA, Achacoso N, et al. Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS. J Natl Cancer Inst. 2012;104:614–621.CrossRef
16.
go back to reference Wernli KJ, DeMartini WB, Ichikawa L, et al. Patterns of Breast Magnetic Resonance Imaging Use in Community Practice. JAMA Intern Med. 2014;174(1):125–132.CrossRef Wernli KJ, DeMartini WB, Ichikawa L, et al. Patterns of Breast Magnetic Resonance Imaging Use in Community Practice. JAMA Intern Med. 2014;174(1):125–132.CrossRef
17.
go back to reference Stout NK, Nekhlyudov L, Li L, et al. Rapid Rise of Breast Magnetic Resonance Imaging Use: Trends from 2000-2011. JAMA Intern Med. 2014; 174(1):114–121.CrossRef Stout NK, Nekhlyudov L, Li L, et al. Rapid Rise of Breast Magnetic Resonance Imaging Use: Trends from 2000-2011. JAMA Intern Med. 2014; 174(1):114–121.CrossRef
18.
go back to reference Brandzel S, Rosenberg DE, Johnson D, et al. Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017;11:199–204. CrossRef Brandzel S, Rosenberg DE, Johnson D, et al. Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017;11:199–204. CrossRef
19.
go back to reference Wernli KJ, Brandzel SD, Buist DSM, Bush M, DeMartini W, Ichikawa L, Haas C, Henderson LM, Johnson D, Kerlikowske K, McColgin D, Miglioretti CL, Nekhlyudov L, Onega T, Rosenberg DE. Comparative effectiveness of surveillance imaging modalities in breast cancer survivors. In press, Final research report to Patient Centered Outcomes Research Institute. 2018. Wernli KJ, Brandzel SD, Buist DSM, Bush M, DeMartini W, Ichikawa L, Haas C, Henderson LM, Johnson D, Kerlikowske K, McColgin D, Miglioretti CL, Nekhlyudov L, Onega T, Rosenberg DE. Comparative effectiveness of surveillance imaging modalities in breast cancer survivors. In press, Final research report to Patient Centered Outcomes Research Institute. 2018.
21.
go back to reference Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, Chrvala CA, Key CR, Poplack SP, Worden JK, Kessler LG. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169:1001–8.CrossRef Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, Chrvala CA, Key CR, Poplack SP, Worden JK, Kessler LG. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169:1001–8.CrossRef
22.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009.
23.
go back to reference Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86.CrossRef Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Shairer C, Mulvihill JJ: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–86.CrossRef
24.
go back to reference Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541–8.CrossRef Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541–8.CrossRef
25.
go back to reference Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst. 1999;91(21):1829–46.CrossRef Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst. 1999;91(21):1829–46.CrossRef
26.
go back to reference Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358–66.CrossRef Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358–66.CrossRef
27.
go back to reference Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, and Bernstein L. Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women. J Natl Cancer Inst. 2007;99(23):1782–1792.CrossRef Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, and Bernstein L. Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women. J Natl Cancer Inst. 2007;99(23):1782–1792.CrossRef
28.
go back to reference Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH. Projecting Individualized Absolute Invasive Breast Cancer Risk in Asian and Pacific Island American Women. J Natl Cancer Inst. 2011;103(12):951–61.CrossRef Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH. Projecting Individualized Absolute Invasive Breast Cancer Risk in Asian and Pacific Island American Women. J Natl Cancer Inst. 2011;103(12):951–61.CrossRef
29.
go back to reference Tice JA, Cummings SR, Smith-Bindman R, et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model. Ann Intern Med. 2008;148(5):337–47.CrossRef Tice JA, Cummings SR, Smith-Bindman R, et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model. Ann Intern Med. 2008;148(5):337–47.CrossRef
31.
go back to reference Patel BK, Lee CS, Kosiorek HE et al. Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study. AJR 2018;210:222–227. CrossRef Patel BK, Lee CS, Kosiorek HE et al. Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study. AJR 2018;210:222–227. CrossRef
34.
go back to reference Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):49–58.CrossRef Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):49–58.CrossRef
35.
go back to reference Sprague BL, Arao RF, Miglioretti DL, et al. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):59–69.CrossRef Sprague BL, Arao RF, Miglioretti DL, et al. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):59–69.CrossRef
Metadata
Title
Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer
Authors
Louise M. Henderson, PhD
Laura Ichikawa, MS
Diana S. M. Buist, PhD
Janie M. Lee, MD
Mary Bush, MN
Dianne Johnson, BA
Tracy Onega, PhD
Larissa Nekhlyudov, MD
Karla Kerlikowske, MD
Diana L. Miglioretti, PhD
Brian L. Sprague, PhD
Karen J. Wernli, PhD
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 10/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05181-6

Other articles of this Issue 10/2019

Journal of General Internal Medicine 10/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.